PO.PS01.12 · 人群科学

美国农业草甘膦使用与早发性结直肠癌死亡率

Agricultural glyphosate use and early-onset colorectal cancer mortality in the United States

海报缩略图:美国农业草甘膦使用与早发性结直肠癌死亡率
编号 6244 展板 6 时间 4/21 02:00–05:00 区域 Section 33 主讲 Jiayu Lin, MPH
分会场 Environmental and Occupational Risk Factors, Infection, and Aging
查看 PDF 下载 PDF 🔒 查看 / 下载完整 PDF 需登录并开通下载套餐 · 查看套餐 / 开通 AACR 官方页面

作者与单位 Authors & Affiliations

Jiayu Lin1, Malia Cortez1, Caroline Nondin1, Seigi Karasaki2, Sam L. S. Chao3, Trang VoPham1

1Epidemiology Program, Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA,2Fred Hutchinson Cancer Center, Seattle, WA,3Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA

摘要 Abstract

中文摘要
目的:早发性结直肠癌(CRC)(50 岁以前确诊)的发病率急剧上升。与 1960 年代出生者相比,1990 年代出生的个体患早发性 CRC 的风险高出四倍。近期证据表明,早年生活中经历的和/或在相对较晚世代中出现的风险因素可能在早发性 CRC 中发挥病因学作用。一种可能促成早发性 CRC 激增的环境暴露是草甘膦,它是世界上使用最广泛的除草剂,自 1996 年抗草甘膦作物引入后使用量大幅增加。据推测,草甘膦通过肠道微生物群失调等机制促进结直肠癌发生。我们的目的是开展一项流行病学研究,考察美国农业草甘膦使用与早发性 CRC 特异性死亡风险之间的关联。 方法:我们从美国国家卫生统计中心提取了 1989-2023 年间美国所有死于早发性 CRC(定义为 50 岁以前死亡)(ICD-9 153.0-153.4、153.6-154.1;ICD-10 C18.0、C18.2-C18.9、C19、C20)个体死亡证明中的死亡率和社会人口学数据。通过将美国地质调查局的全国农业农药施用数据与死亡时的年份和居住县相链接,估算了年平均草甘膦使用量。采用带稳健标准误的准泊松回归,估算草甘膦使用与早发性 CRC 特异性死亡风险之间关联的死亡率比(MRR)及 95% 置信区间(CI),并对个体层面的年龄、性别、种族、族裔、年份、婚姻状况和教育水平以及县级社会经济地位进行校正。 结果:本研究共纳入 108,315 例 50 岁以下的 CRC 死亡病例。我们观察到具有统计学意义的剂量-反应关系,即年平均草甘膦使用量越高,CRC 特异性死亡风险呈递增趋势(最高五分位数(>5.74 kg/km2)与最低五分位数(<=0.08 kg/km2)相比,校正 MRR:1.10,95% CI 1.06-1.13;p 趋势 <0.0001)。 结论:较高的农业草甘膦使用与美国早发性 CRC 特异性死亡风险升高相关。未来研究应通过考察发病结局并利用居住地址史研究全生命历程暴露,进一步探索草甘膦在早发性 CRC 中的作用。
查看英文原文 English abstract
PURPOSE Early-onset colorectal cancer (CRC) (diagnosis before age 50 years) incidence has risen dramatically. Individuals born in the 1990s compared to the 1960s have a four-fold higher risk for early-onset CRC. Recent evidence suggests that risk factors experienced in early life and/or emerging in relatively later generations may play an etiologic role in early-onset CRC. One environmental exposure potentially contributing to the surge in early-onset CRC is glyphosate, the most widely utilized herbicide in the world that substantially increased in usage following the introduction of glyphosate-resistant crops in 1996. Glyphosate is hypothesized to promote colorectal carcinogenesis through mechanisms such as gut microbiome dysbiosis. Our objective was to conduct an epidemiologic study examining the association between agricultural glyphosate use and risk for early-onset CRC-specific mortality in the United States. METHODS We extracted mortality and sociodemographic data from death certificates of all individuals in the United States who died from early-onset CRC (defined as death before age 50) (ICD-9 153.0-153.4, 153.6-154.1; ICD-10 C18.0, C18.2-C18.9, C19, C20) from 1989-2023 from the National Center for Health Statistics. Annual average glyphosate use was estimated by linking nationwide agricultural pesticide application data from the United States Geological Survey with the year and county of residence at death. Quasi-Poisson regression with robust standard errors was used to estimate mortality rate ratios (MRRs) with 95% confidence intervals (CIs) for the association between glyphosate use and early-onset CRC-specific mortality risk adjusted for individual-level age, sex, race, ethnicity, year, marital status, and education level, and county-level socioeconomic status. RESULTS A total of 108,315 deaths from CRC among those <50 years old were included in this study. We observed a statistically significant dose-response relationship, in which higher annual average glyphosate use was associated with incremental increases in risk for CRC-specific mortality (adjusted MRR highest quintile (>5.74 kg/km2) vs. lowest quintile (<=0.08 kg/km2): 1.10, 95% CI 1.06-1.13; p trend <0.0001). CONCLUSIONS Higher agricultural glyphosate use was associated with increased risk for early-onset CRC-specific mortality in the United States. Future research should further explore the role of glyphosate in early-onset CRC through examining incidence outcomes and life-course exposures using residential address histories.
利益披露 Disclosure
J. Lin, None.. M. Cortez, None.. C. Nondin, None.. S. L. S. Chao, None.. T. VoPham, None.

← 返回 AACR 2026 检索